Aryl hydrocarbon receptor is a ligand-dependent transcription factor which has been reported to have connections with tumor metastasis of thyroid carcinoma, neuroblastoma and inflammatory breast cancer [22–24]. The gene discussed is AHR; the disease is thyroid gland carcinoma.